Galderma Investigational Site 8743

Ann Arbor, Michigan 48109-5000

1 studies enrolling now · 3 studies all time

What they study most

Moderate-to-Severe Atopic Dermatitis, Systemic Sclerosis

Studies at this site

• A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis — Recruiting now
• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed